Corrosion-Responsive Self-Healing Coatings

Organic coatings are one of the most popular and powerful strategies for protecting metals against corrosion. They can be applied in different ways, such as by dipping, spraying, electrophoresis, casting, painting, or flow coating. They offer great flexibility of material designs and cost effectiveness. Moreover, self-healing has evolved as a new research topic for protective organic coatings in the last two decades. Responsive materials play a crucial role in this new research field. However, for targeting the development of high-performance self-healing coatings for corrosion protection, it is not sufficient just to focus on smart responsive materials and suitable active agents for self-healing. A better understanding of how coatings can react on different stimuli induced by corrosion, how these stimuli can spread in the coating, and how the released agents can reach the corroding defect is also of high importance. Such knowledge would allow the design of coatings that are optimized for specific applications. Herein, the requirements and possibilities from the corrosion and synthesis perspectives for designing materials for preparing self-healing coatings for corrosion protection are discussed.

Fast-release kinetics of a pH-responsive polymer detected by dynamic contact angles

Polymers conjugated with active agents have applications in biomedicine, anticorrosion, and smart agriculture. When the active agent is used as a drug, corrosion inhibitor, or pesticide, it can be released upon a specific stimulus. The efficiency and the sustainability of active agents are determined by the released kinetics. In this work, we study the fast-release kinetics of 8-hydroxyquinoline (8HQ) from a pH-responsive, random copolymer of methyl methacrylate and 8-quinolinyl-sulfide-ethyl acrylate [P(MMA-co-HQSEA)] by hydrolysis of the β-thiopropionate groups. We used contact angle measurements of sliding drops as an elegant way to characterize the release kinetics. Based on the results gained from ¹H nuclear magnetic resonance measurement, fluorescent intensity measurement, and velocity-dependent contact angle measurement, we found that both the hydrolysis rate and polymer conformation affect the release kinetics of 8HQ from a P(MMA-co-HQSEA) film. Polymer chains collapse and further suppress the release from the inner layer in acidic conditions, while polymer chains in a stretched condition further facilitate the release from the inner layer. As a result, the cumulative release rate of 8HQ is higher in the basic condition than in the acidic condition.

Peptide-Drug Conjugates: A New Hope for Cancer Management

Cancer remains the leading cause of death worldwide despite advances in treatment options for patients. As such, safe and effective therapeutics are required. Short peptides provide advantages to be used in cancer management due to their unique properties, amazing versatility, and progress in biotechnology to overcome peptide limitations. Several appealing peptide-based therapeutic strategies have been developed. Here, we provide an overview of peptide conjugates, the better equivalents of antibody-drug conjugates, as the next generation of drugs for required precise targeting, enhanced cellular permeability, improved drug selectivity, and reduced toxicity for the efficient treatment of cancers. We discuss the basic components of drug conjugates and their release action, including the release of cytotoxins from the linker. We also present peptide-drug conjugates under different stages of clinical development as well as regulatory and other challenges.

Degradable polyprodrugs: design and therapeutic efficiency

Prodrugs are developed to increase the therapeutic properties of drugs and reduce their side effects. Polyprodrugs emerged as highly efficient prodrugs produced by the polymerization of one or several drug monomers. Polyprodrugs can be gradually degraded to release therapeutic agents. The complete degradation of polyprodrugs is an important factor to guarantee the successful disposal of the drug delivery system from the body. The degradation of polyprodrugs and release rate of the drugs can be controlled by the type of covalent bonds linking the monomer drug units in the polymer structure. Therefore, various types of polyprodrugs have been developed based on polyesters, polyanhydrides, polycarbonates, polyurethanes, polyamides, polyketals, polymetallodrugs, polyphosphazenes, and polyimines. Furthermore, the presence of stimuli-responsive groups, such as redox-responsive linkages (disulfide, boronate ester, metal-complex, and oxalate), pH-responsive linkages (ester, imine, hydrazone, acetal, orthoester, P-O and P-N), light-responsive (metal-complex, o-nitrophenyl groups) and enzyme-responsive linkages (ester, peptides) allow for a selective degradation of the polymer backbone in targeted tumors. We envision that new strategies providing a more efficient synergistic therapy will be developed by combining polyprodrugs with gene delivery segments and targeting moieties.

Polymers with Hemiaminal Ether Linkages for pH-Responsive Antibacterial Materials

Antibacterial materials containing biocides suffer from the fact that biocides are usually quickly released and hence display a limited antibacterial ability over a long period of time. To overcome this problem, the antibacterial agent 6-chloropurine is conjugated to a monomer via a hemiaminal ether linkage. The functional monomer is then reacted with a urethane acrylate by photopolymerization to yield thin polymer coatings. The release of the antibacterial agent from the coatings is sustained due to the slow kinetics of the hydrolysis of the hemiaminal ether linkage. Antibacterial performance is achieved against S. aureus and E. coli bacteria. This simple strategy can be applied for the rapid preparation of antibacterial coatings on various substrates and other applications such as antifouling or anticorrosion coatings.

Fighting corrosion with stimuli-responsive polymer conjugates

Corrosion is a financial and enviromental plague which leads to the deterioration of our infrastructures. Using corrosion inhibitors at low concentrations in coatings is one effective method for preventing corrosion. Inspired by the development of polymer-drug conjugates, corrosion inhibitors are incorporated in various polymer structures to create novel materials for hindering corrosion. We discuss the strategies to covalently integrate corrosion inhibitors in polymer structures to form polymer-inhibitor conjugates. Inhibitors are conjugated to polymers via non-labile or stimuli-labile linkages to allow the release of the inhibitors upon onset of corrosion. The application and anticorrosion performance of representative polymers are also discussed.

Therapeutic potential of polypeptide-based conjugates: Rational design and analytical tools that can boost clinical translation

The clinical success of polypeptides as polymeric drugs, covered by the umbrella term "polymer therapeutics," combined with related scientific and technological breakthroughs, explain their exponential growth in the development of polypeptide-drug conjugates as therapeutic agents. A deeper understanding of the biology at relevant pathological sites and the critical biological barriers faced, combined with advances regarding controlled polymerization techniques, material bioresponsiveness, analytical methods, and scale up-manufacture processes, have fostered the development of these nature-mimicking entities. Now, engineered polypeptides have the potential to combat current challenges in the advanced drug delivery field. In this review, we will discuss examples of polypeptide-drug conjugates as single or combination therapies in both preclinical and clinical studies as therapeutics and molecular imaging tools. Importantly, we will critically discuss relevant examples to highlight those parameters relevant to their rational design, such as linking chemistry, the analytical strategies employed, and their physicochemical and biological characterization, that will foster their rapid clinical translation.

Controlling release kinetics of pH-responsive polymer nanoparticles

Polymers with pH-responsive properties display anticorrosion performance.